Cargando…
Paclitaxel Coated Balloon vs. Bare Metal Stent for Endovascular Treatment of Symptomatic Vertebral Artery Origin Stenosis Patients: Protocol for a Randomized Controlled Trial
Background: Stenting treatment for refractory symptomatic patients with vertebral artery origin stenosis (VAOS) is safe; however, there is a high rate of in-stent restenosis. Although drug-eluting stents can reduce the incidence of restenosis to some extent, there is still a risk caused by stent fra...
Autores principales: | Wang, Yabing, Ma, Yan, Gao, Peng, Chen, Yanfei, Yang, Bin, Feng, Yao, Jiao, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874044/ https://www.ncbi.nlm.nih.gov/pubmed/33584491 http://dx.doi.org/10.3389/fneur.2020.579238 |
Ejemplares similares
-
Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
por: Si, Jiang-Hua, et al.
Publicado: (2022) -
Outcomes of Endovascular Stenting in Symptomatic Vertebral Artery Ostial Stenosis
por: El Koussa, Roy, et al.
Publicado: (2022) -
Balloon Angioplasty vs. Stenting for Symptomatic Intracranial Arterial Stenosis
por: Sun, Yaxuan, et al.
Publicado: (2022) -
Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020) -
Bare Metal Stents on Resveratrol-Coated Balloons in Porcine Coronary and Peripheral Arteries
por: Kamann, Stefanie, et al.
Publicado: (2021)